These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 23666762)
21. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Mondragón-Rodríguez S; Basurto-Islas G; Santa-Maria I; Mena R; Binder LI; Avila J; Smith MA; Perry G; García-Sierra F Int J Exp Pathol; 2008 Apr; 89(2):81-90. PubMed ID: 18336525 [TBL] [Abstract][Full Text] [Related]
22. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433 [TBL] [Abstract][Full Text] [Related]
23. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Hoffmann R; Lee VM; Leight S; Varga I; Otvos L Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960 [TBL] [Abstract][Full Text] [Related]
24. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Ghoshal N; Smiley JF; DeMaggio AJ; Hoekstra MF; Cochran EJ; Binder LI; Kuret J Am J Pathol; 1999 Oct; 155(4):1163-72. PubMed ID: 10514399 [TBL] [Abstract][Full Text] [Related]
25. 14-3-3zeta is an effector of tau protein phosphorylation. Hashiguchi M; Sobue K; Paudel HK J Biol Chem; 2000 Aug; 275(33):25247-54. PubMed ID: 10840038 [TBL] [Abstract][Full Text] [Related]
26. Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function. Kim BM; You MH; Chen CH; Lee S; Hong Y; Hong Y; Kimchi A; Zhou XZ; Lee TH Cell Death Dis; 2014 May; 5(5):e1237. PubMed ID: 24853415 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741 [TBL] [Abstract][Full Text] [Related]
28. Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain. Lund H; Cowburn RF; Gustafsson E; Strömberg K; Svensson A; Dahllund L; Malinowsky D; Sunnemark D Brain Pathol; 2013 Jul; 23(4):378-89. PubMed ID: 23088643 [TBL] [Abstract][Full Text] [Related]
29. DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease. Poli M; Gatta LB; Dominici R; Lovati C; Mariani C; Albertini A; Finazzi D Neurosci Lett; 2005 Dec; 389(2):66-70. PubMed ID: 16095818 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer's disease. Naqvi AAT; Jairajpuri DS; Noman OMA; Hussain A; Islam A; Ahmad F; Alajmi MF; Hassan MI J Biomol Struct Dyn; 2020 Aug; 38(13):3892-3907. PubMed ID: 31512980 [TBL] [Abstract][Full Text] [Related]
32. Neurofibrillary tangles and tau phosphorylation. Brion JP; Anderton BH; Authelet M; Dayanandan R; Leroy K; Lovestone S; Octave JN; Pradier L; Touchet N; Tremp G Biochem Soc Symp; 2001; (67):81-8. PubMed ID: 11447842 [TBL] [Abstract][Full Text] [Related]
33. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. Alonso AD; Zaidi T; Novak M; Barra HS; Grundke-Iqbal I; Iqbal K J Biol Chem; 2001 Oct; 276(41):37967-73. PubMed ID: 11495914 [TBL] [Abstract][Full Text] [Related]
34. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985 [TBL] [Abstract][Full Text] [Related]
35. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites. Trojanowski JQ; Mawal-Dewan M; Schmidt ML; Martin J; Lee VM Brain Res; 1993 Aug; 618(2):333-7. PubMed ID: 8374766 [TBL] [Abstract][Full Text] [Related]
36. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Su JH; Cummings BJ; Cotman CW Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559 [TBL] [Abstract][Full Text] [Related]
37. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease. Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459 [TBL] [Abstract][Full Text] [Related]
38. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426 [TBL] [Abstract][Full Text] [Related]
39. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. Pei JJ; Tanaka T; Tung YC; Braak E; Iqbal K; Grundke-Iqbal I J Neuropathol Exp Neurol; 1997 Jan; 56(1):70-8. PubMed ID: 8990130 [TBL] [Abstract][Full Text] [Related]
40. Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. Hashiguchi M; Saito T; Hisanaga S; Hashiguchi T J Biol Chem; 2002 Nov; 277(46):44525-30. PubMed ID: 12226093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]